2007

Albrecht P, Fröhlich R, Hartung HP, Kieseier BC, Methner A. Optical coherence tomography measures axonal loss in multiple sclerosis independently of optic neuritis. Journal of Neurology 2007; 254: 1595-1596.

Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, Clifford DB, Cinque P, Epstein LG, Goodkin K, Gisslen M, Grant I, Heaton RK, Joseph J, Marder K, Marra CM, McArthur JC, Nunn M, Price RW, Pulliam L, Robertson KR, Sacktor N, Valcour V, Wojna VE. Updated research nosology for HIV-associated neurocognitive disorders. Neurology 2007; 69: 1789-1799.

Arendt G, Nolting T, Frisch C, Husstedt IW, Gregor N, Koutsilieri E, Maschke M, Angerer A, Obermann M, Neuen-Jacob E, Adams O, Loeffert S, Riederer P, ter Meulen V, Sopper S for the German Competence Network HIV/AIDS. Intrathecal viral replication and cerebral deficits in different stages of HIV disease. Journal of NeuroVirology 2007; 13: 225-232.

Arendt G, de Nocker D, Giesen HJv, Nolting T. Neuropsychiatric side effects of efavirenz therapy. Expert Opinion on Drug Safety 2007; 6: 147-154.

Arendt G. Neurologische und neuropsychiatrische Aspekte der HIV-Infektion. Grundlagen, Diagnostik und Therapie. In: Brandt T, Hohlfeld R, Noth J, Reichmann H (eds.) Klinische Neurologie. Verlag W. Kohlhammer, Stuttgart, 2007.

Audebert HJ, Haberl RL, Hacke W, Handschu R, Schenkel J, Scibor M, Schleyer AM, Siebler M, Vatankhah B, Wiborg A, Widder B. Telemedizin in der akuten Schlaganfallversorgung. Deutsche Medizinische Wochenschrift 2007; 132: 431-436.

Barkhof F, Polman CH, Radue EW, Kappos L, Freedman MS, Edan G, Hartung HP, Miller DH, Montalbán X, Poppe P, de Vos M, Lasri F, Bauer L, Dahms S, Wagner K, Pohl C, Sandbrink R. MRI effects of interferon-beta-1b in the BENEFIT study: integrated 2-year results. Archives of Neurology 2007; 64: 1292-1298.

Basheer R, Bauer A, Elmenhorst D, Ramesh V, McCarley RW. Sleep deprivation upregulates A1 adenosine receptors in the rat basal forebrain. Neuroreport 2007; 18; 1895-1899.

Buttmann M, Merzyn C, Hofstetter HH, Rieckmann P. Trail, CXCL10 and CCL2 plasma levels during long-term Interferon-beta treatment of patients with multiple sclerosis correlate with flu-like adverse effects but do not predict therapeutic response. Journal of Neuroimmunology2007; 190: 170-176.

Carey LM, Seitz RJ. Functional neuroimaging in stroke recovery and neurorehabilitation: conceptual issues and perspectives. International Journal of Stroke 2007; 2: 245-264.

Cepok S, von Geldern G, Nolting T, Grummel V, Srivastava R, Zhou D, Hartung HP, Adams O, Arendt G, Hemmer B. Viral load determines the B-cell response in the central nervous system during HIV infection. Annals of Neurology 2007; 62: 458-467.

Darling WG, Seitz RJ, Peltier S, Tellmann L, Butler AJ. Visual cortex activation in kinesthetic guidance of reaching. Experimental Brain Research 2007; 179: 607-619.

Dehmel T, Janke A, Hartung HP, Goebel HH, Wiendl H, Kieseier B. The cell-specific expression of metalloproteinase-disintegrins (ADAMs) in inflammatory myopathies. Neurobiology of Disease 2007; 25: 665-674.

Dehnhardt M, Palm C, Vieten A, Bauer A, Pietrzyk U Quantifying the A1AR distribution in peritumoural zones around experimental F98 and C6 brain tumours. Journal of Neuro-Oncology 2007; 85: 49-63.

De Luca MA, Bassareo V, Bauer A, Di Chiara G. Caffeine and accumbens shell dopamine. Journal of Neurochemistry 2007; 103: 157-163.

Diener HC, Elger CE, Hartung HP, Maschke M, Weller M, Deuschl G, Kastrup O, Schuchardt V. Off-Label-Use in der Neurologie. Aktuelle Neurologie 2007; 34: 75-79.

Dirks M, Niessen LW, Koudstaal J, Franke CL, van Oostenbrugge RJ, Dippel DW; Delphi panel [Seitz RJ]. Intravenous thrombolysis in acute ischaemic stroke: from trial exclusion criteria to clinical contraindications. An international Delpi study. Journal of Neurology, Neurosurgery and Psychiatry 2007; 78: 685-689.

Elmenhorst D, Meyer PT, Winz OH, Matusch A, Ermert J, Coenen HH, Basheer R, Haas HL, Zilles K, Bauer A. Sleep deprivation increases A1 adenosine receptor binding in the human brain: a positron emission tomography study. Journal of Neuroscience 2007; 27: 2410-2415.

Elmenhorst D, Meyer PT, Matusch A, Winz OH, Zilles K, Bauer A. Test-retest stability of cerebral A1 adenosine receptor quantification using [18F]CPFPX and PET. European Journal of Nuclear Medicine and Molecular Imaging 2007; 34: 1061-1070.

Filippi M, Hartung HP. What do we really see when we look at MR images? Annals of Neurology 2007; 62: 207-209.

Gold R, Jawad A, Miller DH, Henderson DC, Fassas A, Fierz W, Hartung HP. Expert opinion: Guidelines for the use of natalizumab in multiple sclerosis patients previously treated with immunomodulating therapies. Journal of Neuroimmunology 2007; 187: 156-158.

Gross J, Schnitzler A, Timmermann L, Ploner M. Gamma oscillations in human primary somatosensory cortex reflect pain perception. PLOS Biology 2007; 5: 1168-1173.

Habisch HJ, Schwalenstöcker B, Danzeisen R, Neuhaus O, Hartung HP, Ludolph A. Limited effects of glatiramer acetate in the high-copy number hSOD1-G93A mouse model of ALS. Experimental Neurology 2007; 206: 288-295.

Hacke W, Oertel W, Wick W, Hartung HP, Ringleb PA, Diener HC. Die großen klinischen Studien - Evidenzbasierte Medizin in der Deutschen Neurologie. Aktuelle Neurologie 2007; 34: 386-389.

Hartung HP. McAlpine's Multiple Sclerosis. Book review. New England Journal of Medicine2007; 356; 534-535.

Hartung HP, Polman C, Bertolotto A, Deisenhammer F, Giovannoni G, Havrdova E, Hemmer B, Hillert J, Kappos L, Kieseier B, Killestein J, Malcus C, Comabella M, Pachner A, Schellekens H, Sellebjerg F, Selmaj K, Soelberg Sorensen P. Neutralising antibodies to interferon b in multiple sclerosis: Expert panel report. Journal of Neurology 2007; 254: 827-837.

Hemmer B, Stüve O. Revised criteria for neuromyelitis optica - a new diagnostic standard? Nature Clinical Practice Neurology 2007; 3: 132-133.

Hemmer B, Hartung HP. Toward the development of rational therapies in multiple sclerosis: what is on the horizon? Annals of Neurology 2007; 62: 314-326.

Hemmer B, Töpfner N, Hartung HP. Immunopathogenesis of Multiple Sclerosis. In: Gilman S (ed.) Neurobiology of Disease. Elsevier Academic Press, 2007; 197-204.

Hofstetter HH, Grau C, Buttmann M, Forsthuber TG, Gaupp S, Toyka KV, Gold R. The PLPp-specific T-cell population promoted by pertussis toxin is characterized by high frequencies of IL-17-producing cells. Cytokine 2007; 40: 35-43.

Hofstetter HH, Toyka KV, Tary-Lehmann M, Lehmann PV. Kinetics and organ distribution of IL-17-producing CD4 cells in proteolipid protein 139-151 peptide-induced experimental autoimmune encephalomyelitis of SJL mice. Journal of Immunology 2007; 178: 1372-1378.

Hofstetter HH, Kovalovsky A, Shive CL, Lehmann PV, Forsthuber TG. Neonatal induction of myelin-specific Th1/Th17 immunity does not result in experimental autoimmune encephalomyelitis and can protect against the disease in adulthood. Journal of Neuroimmunology 2007; 187: 20-30.

Hohlfeld T, Weber AA, Junghans U, Schumacher M, Boucher M, Schrör K, Siebler M. Variable platelet response to aspirin in patients with ischemic stroke. Cerebrovascular Diseases2007; 24: 43-50.

Hu W, Janke A, Ortler S, Hartung HP, Leder C, Kieseier BC, Wiendl H. Expression of CD28-related costimulatory molecule and its ligand in inflammatory neuropathies. Neurology 2007; 68: 277-282.

Illes S, Fleischer W, Siebler M, Hartung HP, Dihné M. Development and pharmacological modulation of embryonic stem cell-derived neuronal network activity. Experimental Neurology 2007; 207: 171-176.

Jander S, Schroeter M, Saleh A. Imaging inflammation in acute brain ischemia. Stroke 2007; 38: 642-645.

Jander S. Immunsuppressive Therapie: Myasthenia gravis. Psychoneuro 2007; 33: 177-182.

Jander S. Myasthenia gravis. In: Einhäupl KM, Weiller C, Diener HC, Busch EW (eds.) Neurologie 2007, Fortbildungsband der Deutschen Gesellschaft für Neurologie, Georg Thieme Verlag, Stuttgart, 2007; 149-151.

Jörgens S, Kleiser R, Indefrey R, Seitz RJ. Handedness and functional MRI-activation patterns in sentence processing. Neuroreport 2007; 18: 1339-1343.

Johann V, Schiefer J, Sass C, Mey J, Brook G, Kruttgen A, Schlangen C, Bernreuther C, Schachner M, Dihné M, Kosinski CM. Time of transplantation and cell preparation determine neural stem cell survival in a mouse model of Huntington's disease. Experimental Brain Research 2007; 177: 458-470.

Jonas M, Biermann-Ruben K, Kessler K, Lange R, Bäumer T, Siebner H, Schnitzler A, Münchau A. Observation of a finger or an object movement primes imitative responses differentially. Experimental Brain Research 2007; 177: 255-265.

Jonas M, Siebner HR, Biermann-Ruben K, Kessler K, Bäumer T, Büchel C, Schnitzler A, Münchau A. Do simple intransitive finger movements consistently activate frontoparietal mirror neuron areas in humans? Neuroimage 2007; 36 Suppl. 2: 44-53.

Kappos L, Bates D, Hartung HP, Havrdova E, Miller D, Polman CH, Ravnborg M, Hauser SL, Rudick RA, Weiner HL, O'Connor PW, King J, Radue EW, Yousry T, Major EO, Clifford DB. Natalizumab treatment for multiple sclerosis: recommendations for patient selection and monitoring. Lancet Neurology 2007; 6: 431-441.

Kappos L, Freedman MS, Polman CH, Edan G, Hartung HP, Miller DH, Montalbán X, Barkhof F, Radü EW, Bauer L, Dahms S, Lanius V, Pohl C, Sandbrink R, for the BENEFIT study group. Effect of early versus delayed interferon beta-1b treatment on disability after a first clinical event suggestive of multiple sclerosis: a 3-year follow-up analysis of the BENEFIT study. Lancet 2007; 370: 389-397.

Kappos L, Montalban X, Hartung HP, Freedman M, Polman C; for the BENEFIT steering committee. Treating clinically isolated syndromes suggestive of MS - Authors' reply. Lancet 2007; 370: 2000-2001.

Kieseier BC, Hartung HP. Interferon-beta and neuroprotection in multiple sclerosis - facts, hopes and phantasies. Experimental Neurology 2007; 203: 1-4.

Kieseier BC, Wiendl H. Oral disease-modifying treatments for multiple sclerosis: the story so far. CNS Drugs 2007; 21: 483-502.

Kieseier BC, Hu W, Hartung HP. Schwann cells as immunomodulatory cells. In: Armati P (ed.). The Schwann cell - an extraordinary tale. Cambridge University Press, 2007; 118-125.

Kieseier BC, Wiendl H, Hemmer B, Hartung HP. Treatment and treatment trials in MS. Current Opinion in Neurology 2007; 20: 286-293.

Klatt J, Hartung HP, Hohlfeld R. FTY720 (Fingolimod) als neue Therapiemöglichkeit der Multiplen Sklerose. Nervenarzt 2007; 78: 1200-1208.

Kleinschnitz C, Meuth SG, Kieseier BC, Wiendl H. Immunotherapeutic approaches in MS: Update on pathophysiology and emerging agents or strategies 2006. Endocrine, Metabolic & Immune Disorders - Drug Targets 2007; 7: 35-63.

Kleinschnitz C, Meuth SG, Kieseier BC, Wiendl H. Multiple-Sklerose-Update zur Pathophysiologie und neuen immuntherapeutischen Ansätzen. Nervenarzt 2007; 78: 883-911.

Kleinschnitz C, Meuth S, Stüve O, Kieseier BC, Wiendl H. Multiple sclerosis therapy: An update on recently finished trials. Journal of Neurology 2007; 254: 1473-1490.

Koch A, Zacharowski K, Böhm O, Stevens M, Lipfert P, Giesen HJv, Freynhagen R. NO and pro-inflammatory cytokines in correlation with pain intensity of chronic pain patients. Inflammation Research 2007; 56: 32-37.

Konen CS, Kleiser R, Bremmer F, Seitz RJ. Different cortical activations during visuospatial attention and the intention to perform a saccade. Experimental Brain Research 2007; 182: 333-341.

Kopadze T, Dehmel T, Mylius HA, Hartung HP, Wiendl H, Kieseier BC. Treosulfan impedes the migration of immunocompetent cells. Journal of Neurology 2007; 254: 1457-1458.

Krumbholz M, Theil D, Steinmeyer F, Cepok S, Hemmer B, Hofbauer M, Farina C, Derfuss T, Junker A, Arzberger T, Sinicina I, Hartle C, Newcombe J, Hohlfeld R, Meinl E. CCL19 is constitutively expressed in the CNS, up-regulated in neuroinflammation, active and also inactive multiple sclerosis lesions. Journal of Neuroimmunology 2007; 190: 72-9.

Kuhle J, Pohl C, Mehling M, Edan G, Freedman MS, Hartung HP, Polman CH, Miller DH, Montalban X, Barkhof F, Bauer L, Dahms S, Lindberg R, Kappos L, Sandbrink R. Lack of association between antimyelin antibodies and progression to multiple sclerosis. New England Journal of Medicine 2007; 356: 371-378.

Lang PA, Schenck M, Nicolay JP, Becker JU, Kempe DS, Lupescu A, Koka S, Eisele K, Klarl BA, Rubben H, Schmid KW, Mann K, Hildenbrand S, Hefter H, Huber SM, Wieder T, Erhardt A, Haussinger D, Gulbins E, Lang F. Liver cell death and anemia in Wilson disease involve acid sphingomyelinase and ceramide. Nature Medicine 2007; 13: 164-170.

Lehmann HC, Lopez PH, Zhang G, Ngyuen T, Zhang J, Kieseier BC, Mori S, Sheikh KA. Passive immunization with anti-ganglioside antibodies directly inhibits axon regeneration in an animal model. Journal of Neuroscience 2007; 27: 27-34.

Lehmann HC, Koehne A, Meyer zu Hörste G, Dehmel T, Kiehl O, Hartung HP, Kastenbauer S, Kieseier BC. Role of nitric oxide as mediator of nerve injury in inflammatory neuropathies. Journal of Neuropathology and Experimental Neurology 2007; 66: 305-312.

Lehmann HC, Hartung HP, Kieseier BC. Leopold Ordenstein: on paralysis agitans and multiple sclerosis. Multiple Sclerosis 2007; 13: 1195-1199.

Lehmann HC, Hartung HP, Hetzel GR, Kieseier BC. Plasmapherese als Therapieoption bei neurologischen Erkrankungen. Nervenarzt 2007; 78: 166-176.

Lehmann HC, Köhne A, Meyer zu Hörste G, Kieseier BC. Incidence of Guillain-Barré-syndrome in Germany. Journal of the Peripheral Nervous System 2007; 12: 285.

Lindenberg R, Fangerau H, Seitz RJ. "Broca's area" as a collective term? Brain and Language 2007; 102: 22-29.

Lindenberg R, Scheef L. Supramodal language comprehension: role of the left temporal lobe for listening and reading. Neuropsychologia 2007: 45: 2407-2415.

Matusch A, Hurlemann R, Rota Kops E, Winz OH, Elmenhorst D, Herzog H, Zilles K, Bauer A. Acute S-ketamine application does not alter cerebral [18F] altanserin binding: a pilot PET study in humans. Journal of Neural Transmission 2007; 114: 1433-1442.

Menge T, Kieseier BC, Nessler S, Hemmer B, Hartung HP, Stüve O. Acute disseminated encephalomyelitis: an acute hit against the brain. Current Opinion in Neurology 2007; 20: 247-254.

Menge T, Hemmer B, Nessler S, Zhou D, Kieseier BC, Hartung HP. Immunopathogenesis of Multiple Sclerosis: Overwiew. In: Zhang J (ed.) Immune Regulation and Immunotherapy in Autoimmune Disease Springer, New York, 2007; 171-187.

Menge T, von Büdingen HC, Lalive PH, Genain CP. Relevant antibody subsets against MOG recognize conformational epitopes exclusively exposed in solid-phase ELISA. European Journal of Immunology 2007; 37: 3229-3239.

Meyer PT, Elmenhorst D, Boy C, Winz O, Matusch A, Zilles K, Bauer A. Effect of aging on cerebral A1 adenosine receptors: A [18F] CPFPX PET study in humans. Neurobiology of Aging 2007; 28: 1914-1924.

Meyer zu Hörste G, Hartung HP, Kieseier BC. From bench to bedside - experimental rationale for immune-specific therapies in the inflamed peripheral nerve. Nature Clinical Practice Neurology 2007; 3: 198-211.

Müller K, Bütefisch CM, Seitz RJ, Hömberg V. Mental practice improves hand function after hemiparetic stroke. Restorative Neurology and Neuroscience 2007; 25: 501-511.

Münch C, Meyer R, Linke P, Meyer T, Ludolph AC, Haas J, Hemmer B. The p150 subunit of dynactin (DCTN1) gene in multiple sclerosis. Acta Neurologica Scandinavica 2007; 116: 231-234.

Nessler S, Boretius S, Stadelmann C, Bittner A, Merkler D, Hartung HP, Michaelis T, Brück W, Frahm J, Sommer N, Hemmer B. Early MRI changes in a mouse model of multiple sclerosis are predictive of severe inflammatory tissue damage. Brain 2007; 130: 2186-2198.

Neuhaus O, Saleh A, van Oosterhout A, Siebler M. Cerebellar infarction after gamma knife radiosurgery of a vestibular schwannoma. Neurology 2007; 68: 590.

Neuhaus O, Kieseier BC, Hartung HP. Pharmacokinetics and pharmacodynamics of the interferon-betas, glatiramer acetate, and mitoxantrone in multiple sclerosis. Journal of the Neurological Sciences 2007; 259: 27-37.

Neuhaus O, Hartung HP. Evaluation of atorvastatin and simvastatin for treatment of mutliple sclerosis. Expert Review of Neurotherapeutics 2007; 7: 547-556.

Neuhaus O, Kieseier BC, Hartung HP. Immunosuppressive agents in multiple sclerosis. Neurotherapeutics 2007; 4: 654-660.

Nickel J, Jörgens S, Bussfeld P, Seitz RJ. Asmyptomatic motor cortex displacement due to a giant arachnoid cyst. Neurocase 2007; 13: 328-333.

Nielsen JM, Moraal B, Polman CH, Poppe P, de Vos M, Freedman MS, Kappos L, Barkhof F, Bauer L, Pohl C, Sandbrink R, Hartung HP, Uitdehaag BMJ. Classification of patients with a clinically isolated syndrome based on signs and symptoms is supported by MRI results. Multiple Sclerosis 2007; 13: 717-21.

Ploner M, Platzen J, Pollok B, Gross J, Schnitzler A. Evoked response amplitudes from somatosensory cortices do not determine reaction times to tactile stimuli. European Journal of Neuroscience 2007; 25: 3734-3741.

Pollok B, Butz M, Gross J, Schnitzler A. Intercerebellar coupling contributes to bimanual coordination. Journal of Cognitive Neuroscience 2007; 19: 704-719.

Saleh A, Schroeter M, Ringelstein A, Hartung HP, Siebler M, Moedder U, Jander S. Iron oxide particle-enhanced MRI suggests variability of brain inflammation at early stages after ischemic stroke. Stroke 2007; 38: 2733-2737.

Schäfer R, Popp K, Jörgens S, Lindenberg R, Franz M, Seitz RJ. Alexithymia-like disorder in right anterior cingulate infarction. Neurocase 2007; 13: 201-208.

Schroeter M, Kieseier BC, Köller H, Hartung HP. Immune-Mediated Neuropathies. In: Gilman S (ed.) Neurobiology of Disease. Elsevier Academic Press, London, 2007; 205-215.

Sergeeva OA, Fleischer W, Chepkova AN, Warskulat U, Häussinger D, Siebler M, Haas HL. GABAA-receptor modification in taurine transporter knockout mice causes striatal disinhibition. Journal of Physiology 2007; 585: 539-548.

Siebler M. What is hot in neurosonology? International Journal of Stroke 2007; 2: 109-110.

Siglienti I, Chan A, Kleinschnitz C, Jander S, Toyka KV, Gold R, Stoll G. Downregulation of transforming growth factor-beta2 facilitates inflammation in the central nervous system by reciprocal astrocyte/microglia interactions. Journal of Neuropathology and Experimental Neurology 2007; 66: 47-56.

Sinis N, Schaller HE, Schulte-Eversum C, Lanaras T, Schlosshauer B, Doser M, Dietz K, Rösner H, Müller HW, Haerle M. Comparative neuro tissue engineering using different nerve guide implants. Acta Neurochirurgica Suppl. 2007; 100: 61-64.

Sinis N, Schaller HE, Becker ST, Schlosshauer B, Doser M, Rösner H, Oberhoffner S, Müller HW, Haerle M. Long nerve gaps limit the regenerative potential of bioartificial nerve conduits filled with Schwann cells. Restorative Neurology and Neuroscience 2007; 25: 131-141.

Stoeckel MC, Meisel S, Wittsack HJ, Seitz RJ. Pattern of cortex and white matter involvement in severe middle cerebral artery ischemia. Journal of Neuroimaging 2007; 17: 131-140.

Stoeckel MC, Pollok B, Schnitzler A, Seitz RJ. Studying the human somatosensory hand area: A new way to compare fMRI and MEG. Journal of Neuroscience Methods 2007; 164: 280-291.

Stüve O, Marra CM, Cravens PD, Singh MP, Hu W, Lovett-Racke A, Monson NL, Phillips JT, Cohen Tervaert JW, Nash RA, Hartung HP, Kieseier BC, Racke MM, Frohman EM, Hemmer B. Potential risk of progressive multifocal leukoencephalopathy with natalizumab therapy - possible interventions. Archives of Neurology 2007; 64: 169-176.

Stüve O, Cravens PD, Singh MP, Frohman EM, Phillips JT, Remington G, Hu W, Hemmer B, Olek MJ, Monson NL, Racke MK. High incidence of post-lumbar puncture headaches in patients with multiple sclerosis treated with natalizumab: role of intrathecal leukocytes. Archives of Neurology 2007; 64: 1055-1056.

Turowski B, Hanggi D, Siebler M. Intracranial bilateral vertebral artery dissection during antiocoagulation after cerebral venous and sinus thrombosis (CSVT). Acta Neurochirurgica2007; 149: 793-797.

Voges J, Hilker R, Botzel K, Kiening KL, Kloss M, Kupsch A, Schnitzler A, Schneider GH, Steude U, Deuschl G, Pinsker MO. Thirty days complication rate following surgery performed for deep-brain-stimulation. Movement Disorders 2007; 22: 1486-1489.

von Geldern G, Cepok S, Nolting T, Du Y, Grummel V, Adams O, Hartung HP, Arendt G, Hemmer B. CD8 T-cell subsets and viral load in the cerebrospinal fluid of therapy-naive HIV-infected individuals. AIDS 2007; 21: 250-253.

Watson NF, Woo D, Doherty MJ, Frohman EM, Racke MK, de Baets M, Hartung HP, Kieseier BC, Stüve O. Humoral immune responses after rabies infection. Archives of Neurology2007; 64: 1355-1356.

Weber MS, Stuve O, Neuhaus O, Hartung HP, Zamvil SS. Spotlight on statins. International MS Journal 2007; 14: 93-97.

Weis-Müller BT, Huber R, Spivak-Dats A, Turowski B, Seitz R, Siebler M, Sandmann W. Stellenwert der Revaskularisation eines aktuen Karotisverschlusses. Der Chirurg 2007; 78: 1041-1048.

Wiendl H, Kieseier BC, Weissert R, Mylius HA, Pichlmeier U, Hartung HP, Melms A, Kuker W, Weller M. Treatment of active secondary progressive multiple sclerosis with treosulfan. Journal of Neurology 2007; 254: 884-889.

Wojtecki L, Südmeyer M, Schnitzler A. Therapie des idiopathischen Parkinson-Syndroms. Deutsches Ärzteblatt 2007; 104: 2221-2230.

Wojtecki L, Nickel J, Timmermann L, Maarouf M, Suedmeyer M, Schneider F, Seitz RJ, Voges J, Sturm V, Schnitzler A. Pathological crying induced by deep brain stimulation. Movement Disorders 2007; 22: 1314-1316.

Zipp F, Waiczies S, Aktas O, Neuhaus O, Hemmer B, Schraven B, Nitsch R, Hartung HP. Impact of HMG-CoA reductase inhibition on brain pathology.Trends in Pharmacological Sciences 2007; 28: 342-349.

MediathekInformation und Wissen
LageplanSo finden Sie uns